drugset / Trial / NCT00819767
Efficacy and Safety of Aliskiren in Patients With Mild to Moderate Hypertension During Exercise
RandomizedParallel-groupDouble-blindTreatment
Summary
This study compared the blunting effect of aliskiren and valsartan monotherapies on exercise-induced rises in systolic blood pressure in patients with mild to moderate essential hypertension.
Timeline
- Start
- 2009-02
- Primary completion
- 2009-10
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aliskiren | Small molecule | 300 mg | Oral |
| Comparator | Valsartan | Small molecule | 320 mg | Oral |